Scopus by Title (Ref)

Atopic dermatitis

Allergy Asthma and Clinical Immunology

December 2024

Carr S.

Open Access

Human-Induced Pluripotent Stem Cell‒Derived Keratinocytes, as Therapeutic Option in Vitiligo

Methods in Molecular Biology

2024

Arjmand B.

Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents

Frontiers in Medicine

2023

Caffarelli C.

Open Access

Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)

Italian Journal of Pediatrics

December 2022

Galli E.

Open Access

The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial

Clinical and Experimental Dermatology

May 2022

Azizzadeh M.

Association between Topical Calcineurin Inhibitor Use and Risk of Cancer, including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis

JAMA Dermatology

May 2021

Lam M.

Open Access

Topical Calcineurin Inhibitors

Comprehensive Dermatologic Drug Therapy Fourth Edition

1 January 2020

Chehade A.

What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?

Journal of Cutaneous Medicine and Surgery

1 September 2019

Hanna S.

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East

Saudi Journal of Ophthalmology

April - June 2019

Fiorentini S.F.

Open Access